Vedolizumab in Pediatric inflammatory bowel diseases: a retrospective multi-center experience from the paediatric IBD Porto group of ESPGHAN
Vedolizumab (VDZ) has proven as an effective medication in adult Inflammatory Bowel Disease (IBD). There has been increased off-label use of VDZ also in children but with very limited published experience. Therefore we aimed to describe the short-term effectiveness and safety of VDZ in children with...
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Language: | English |
| Published: |
Oxford University Press
2017
|